JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 23 February 2004. doi:10.1083/jcb1645iti3
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 164, Number 5, 633-633
This Article
Right arrow Full Text (PDF, 652K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

The nucleus shuns MAPK



Active MAPK (green) is excluded from the nucleus (red) after differentiation (right).

Upon differentiation, many cell types no longer proliferate in response to growth factor–activated MAPK. But MAPK has more than just mitogenic effects, and the cells must still activate and respond to MAPK to adjust lipid metabolism, protein synthesis, and other cellular functions. On page 689, Smith et al. identify a simple, yet until now elusive, mechanism by which cells uncouple MAPK's proliferative effects from its other functions.

The strategy is based on compartmentalization. To bring about cell division, MAPK phosphorylates nuclear substrates such as Elk-1. But its nonproliferation substrates are cytoplasmic. So the simple fix to stop division in differentiated cells, as Smith and colleagues show, is to prevent MAPK from entering the nucleus. The group uses retinoic acid to induce differentiation in both embryonic stem cells and an embryonic carcinoma cell line. After treatment, activated MAPK—which had resided in both the nucleus and cytoplasm of undifferentiated cells—was restricted to the cytoplasm, as were its phosphorylated substrates.

Since nuclear export is not required for this change in localization, MAPK import must be blocked somehow. An intact cytoskeleton is required for the nuclear exclusion, so the authors speculate that differentiation changes actin and microtubule dynamics and cellular trafficking such that MAPK is continually transported away from nuclear pores. {blacksquare}



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Regulation of Ras–MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells
Elizabeth R. Smith, Jennifer L. Smedberg, Malgorzata E. Rula, and Xiang-Xi Xu
J. Cell Biol. 2004 164: 689-699. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 652K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents